CompletedNCT06728748
Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy
Studying Congenital adrenal hyperplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Principal Investigator
- Federico Baronio, MDIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment
- 29 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2025
Study locations (4)
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy
- IRCCS Ospedale San Raffaele, Milan, Milano, Italy
- Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino, Torino, Italy
- Azienda Ospedaliera Universitaria Integrata Verona:, Verona, Verona, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06728748 on ClinicalTrials.govOther trials for Congenital adrenal hyperplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07159841A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)Crinetics Pharmaceuticals Inc.
- RECRUITINGPHASE3NCT07144163A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaCrinetics Pharmaceuticals Inc.
- RECRUITINGPHASE2NCT07187375Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years OldNeurocrine Biosciences
- RECRUITINGNANCT07473804Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)IRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT06712823An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894Crinetics Pharmaceuticals Inc.
- RECRUITINGNANCT07099456Fertility And Sexual Function In CAH: CALLIOPEUniversity of Roma La Sapienza
- RECRUITINGPHASE1, PHASE2NCT05669950A Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaH. Lundbeck A/S
- RECRUITINGNCT06754423Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase DeficiencyIRCCS Azienda Ospedaliero-Universitaria di Bologna